St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist.
暂无分享,去创建一个
E. Basch | H. Boon | C. Ulbricht | E. Ernst | P. Hammerness | S. Basch | Steve Bent | E. Barrette | Ivo Foppa | Paul G. Hammerness
[1] W. Kirch,et al. Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. , 2008, British journal of clinical pharmacology.
[2] Eric Plotnick. Research abstracts , 2003 .
[3] P. Oakeshott,et al. Interactions of the oral contraceptive pill with antibiotics and St John's work: knowledge of female college students. , 2002, Family practice.
[4] R. Robinson,et al. Hypertensive crisis associated with St. John's Wort. , 2002, The American journal of medicine.
[5] Norma Pugh,et al. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. , 2002, JAMA.
[6] S. Crowe,et al. Delayed emergence and St. John's wort. , 2002, Anesthesiology.
[7] D. Menkes,et al. St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[8] J. Brockmöller,et al. Decreased Plasma Levels of Amitriptyline and Its Metabolites on Comedication With an Extract From St. John’s Wort (Hypericum perforatum) , 2002, Journal of clinical psychopharmacology.
[9] I. Schweitzer,et al. A Case of Mania Induced by Hyperlcum , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[10] M. Spinella,et al. Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury , 2002, Brain injury.
[11] K. M. Lin,et al. An open trial of nifedipine-herb interactions Nifedipine with St Johns wort, Ginseng or Ginkgo biloba , 2001 .
[12] A. Fujimura,et al. Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin , 2001, Clinical pharmacology and therapeutics.
[13] M. Levine,et al. Evaluation of the Association Between St. John's Wort and Elevated Thyroid‐Stimulating Hormone , 2001, Pharmacotherapy.
[14] D. Kroll,et al. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum). , 2001, Biochemical pharmacology.
[15] B. Jaber,et al. Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] W. Scholte,et al. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)]. , 2001, Nederlands tijdschrift voor geneeskunde.
[17] J. Cott,et al. Herb-Drug Interactions: Focus on Pharmacokinetics , 2001, CNS Spectrums.
[18] T. Kaptchuk,et al. Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey , 2001, Annals of Internal Medicine.
[19] N. Banner,et al. Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[20] T. Baghai,et al. Neuroendocrine Effects of Hypericum Extract WS 5570 in 12 Healthy Male Volunteers , 2001, Pharmacopsychiatry.
[21] B. Gurley,et al. St John's Wort: A Hidden Risk for Transplant Patients , 2001, Progress in transplantation.
[22] J. Bhopal,et al. St John's Wort-Induced Sexual Dysfunction , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[23] J. Drewe,et al. [St. John's wort: a pharmaceutical with potentially dangerous interactions]. , 2001, Praxis.
[24] D. Ladner,et al. Synergistic toxicity of δ‐aminolaevulinic acid‐induced protoporphyrin IX used for photodiagnosis and hypericum extract, a herbal antidepressant , 2001, The British journal of dermatology.
[25] J. Schulte‐Mönting,et al. Single-dose and steady-state administration of Hypericum perforatum extract (St John's Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation. , 2001, Archives of dermatology.
[26] F. Squadrito,et al. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. , 2001, Pharmacopsychiatry.
[27] J. Beijnen,et al. Drug interaction between St John's wort and nevirapine. , 2001, AIDS.
[28] M. Seeman,et al. Adverse Reactions to St John's Wort , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[29] A. Prince,et al. Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection , 2001, Antimicrobial Agents and Chemotherapy.
[30] B. Gurley,et al. HERBAL SUPPLEMENTS: A POTENTIAL FOR DRUG INTERACTIONS IN TRANSPLANT RECIPIENTS , 2001, Transplantation.
[31] J. Greeson,et al. St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature , 2001, Psychopharmacology.
[32] L. Miller. Drug Interactions Known or Potentially Associated with St. John’s Wort , 2001 .
[33] P. Nathan. Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology , 2001, Journal of psychopharmacology.
[34] R. Laird,et al. Psychotic Episode During Use of St. John's Wort , 2001 .
[35] V. Schulz. [Incidence and clinical relevance of interactions and side-effects of hypericum preparations]. , 2000, Praxis.
[36] S. Piscitelli,et al. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers , 2000, Clinical pharmacology and therapeutics.
[37] P. Meier,et al. St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4 , 2000, Clinical pharmacology and therapeutics.
[38] G. Gerken,et al. Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. , 2000, Journal of hepatology.
[39] D. Roberts,et al. Erythroderma associated with St John’s wort , 2000, The British journal of dermatology.
[40] K. Budde,et al. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. , 2000, International journal of clinical pharmacology and therapeutics.
[41] P. Assalian. Sildenafil for St. John Wort–Induced Sexual Dysfunction , 2000, Journal of sex & marital therapy.
[42] J. Sprung,et al. A possible cause of cardiovascular collapse during anesthesia: long-term use of St. John's Wort. , 2000, Journal of clinical anesthesia.
[43] L. Taylor,et al. An open-label trial of St. John's Wort (Hypericum perforatum) in obsessive-compulsive disorder. , 2000, The Journal of clinical psychiatry.
[44] S. Lal,et al. St. John's wort and schizophrenia. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[45] W. Müller,et al. Inhibition of Synaptosomal Uptake of 3H-L-glutamate and 3H-GABA by Hyperforin, a Major Constituent of St. John's Wort: The Role of Amiloride Sensitive Sodium Conductive Pathways , 2000, Neuropsychopharmacology.
[46] R. Obach,et al. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. , 2000, The Journal of pharmacology and experimental therapeutics.
[47] J. Arnason,et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[48] L. Moore,et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] T. Breidenbach,et al. Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum) , 2000, Transplantation.
[50] R. Sommi,et al. Consumer Use of St. John's Wort: A Survey on Effectiveness, Safety, and Tolerability , 2000, Pharmacotherapy.
[51] E. Kantor,et al. PHARMACOKINETICS AND DRUG DISPOSITION St John’s Wort: Effect on CYP3A4 activity , 2000 .
[52] Dr. Peter H. Yu. Effect of the Hypericum Perforatum Extract on Serotonin Turnover in the Mouse Brain , 2000, Pharmacopsychiatry.
[53] E. Schrader. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mildmoderate depression , 2000, International clinical psychopharmacology.
[54] T. M. Brown. Acute St. John's wort toxicity. , 2000, The American journal of emergency medicine.
[55] M. Lane-Brown. Photosensitivity associated with herbal preparations off St John's wort (Hypericum perforatum) , 2000, The Medical journal of Australia.
[56] F. Ruschitzka,et al. Acute heart transplant rejection due to Saint John's wort , 2000, The Lancet.
[57] J. Falloon,et al. Indinavir concentrations and St John's wort , 2000, The Lancet.
[58] Q. Yue,et al. Safety of St John's wort (Hypericum perforatum) , 2000, The Lancet.
[59] A. Mallinger,et al. St. John's Wort: three cases of possible mania induction. , 2000, Journal of clinical psychopharmacology.
[60] B. Gaster,et al. St John's wort for depression: a systematic review. , 2000, Archives of internal medicine.
[61] S. Risch,et al. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. , 2000, Life sciences.
[62] A. Fugh-Berman. Herb-drug interactions , 2000, The Lancet.
[63] L. S. Koupparis. Harmless herbs: a cause for concern? , 2000, Anaesthesia.
[64] E. Esposito,et al. Effect of Acute Administration of Hypericum Perforatum-CO2 Extract on Dopamine and Serotonin Release in the Rat Central Nervous System , 2000, Pharmacopsychiatry.
[65] C. Bench,et al. Mania in a patient receiving testosterone replacement post-orchidectomy taking St John’s wort and sertraline , 2000, Journal of psychopharmacology.
[66] A. Nierenberg,et al. Mania associated with St. John’s wort , 1999, Biological Psychiatry.
[67] I. Roots,et al. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) , 1999, Clinical pharmacology and therapeutics.
[68] J. Streltzer,et al. St. John's wort for depression: a meta-analysis of well-defined clinical trials. , 1999, The Journal of nervous and mental disease.
[69] S. Lippmann,et al. Herbal medicines as a factor in delirium. , 1999, Psychiatric services.
[70] J. Simon,et al. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria , 1999, The Lancet.
[71] V. Giambanco,et al. St. John's Wort and Antidepressant Drug Interactions in the Elderly , 1999, Journal of geriatric psychiatry and neurology.
[72] H. Taguchi,et al. Pentamidine-Induced Hemolytic Anemia in an AIDS Patient , 1999, The Annals of pharmacotherapy.
[73] D. Kroll,et al. Potential Metabolic Interaction between St. John's Wort and Theophylline , 1999, The Annals of pharmacotherapy.
[74] W. Patton,et al. Inhibition of Human Sperm Motility by Specific Herbs Used in Alternative Medicine , 1999, Journal of Assisted Reproduction and Genetics.
[75] R. Kaufmann,et al. Phototoxic effects of Hypericum extract in cultures of human keratinocytes compared with those of psoralen. , 1999, Photochemistry and photobiology.
[76] R. Kaufmann,et al. Phototoxic Effects of Hypericum Extract in Cultures of Human Keratinocytes Compared with Those of Psoralen , 1999 .
[77] J. Neary,et al. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes , 1999, Brain Research.
[78] C. Schneck. St. John's wort and hypomania. , 1998, The Journal of clinical psychiatry.
[79] R. Kessler,et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.
[80] L. Cohen,et al. St John's wort during pregnancy. , 1998, JAMA.
[81] V. Zlotnik,et al. Neuropharmacology of St. John's Wort (Hypericum) , 1998, The Annals of pharmacotherapy.
[82] G. Bove. Acute neuropathy after exposure to sun in a patient treated with St John's Wort , 1998, The Lancet.
[83] E. Ernst,et al. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.) , 1998, European Journal of Clinical Pharmacology.
[84] S S Chatterjee,et al. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models. , 1998, Pharmacopsychiatry.
[85] S. Chatterjee,et al. Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers , 1998, Pharmacopsychiatry.
[86] B. Meier,et al. Hypericum treatment of mild–moderate depression in a placebo–controlled study. A prospective, double–blind, randomized, placebo–controlled, multicentre study , 1998 .
[87] R. Raffa. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding. , 1998, Life sciences.
[88] J. Gordon. SSRIs and St.John's Wort: possible toxicity? , 1998, American family physician.
[89] Miller Al. St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions. , 1998 .
[90] M. Hazzard. Klaus Linde, Gilbert Ramirez, Cynthia D. Mulrow, Andrej Pauls, Wolfgang Weidenhammer, and Dieter Melchart. (1996). St. John's wort for depression—An overview and meta-analysis of randomized clinical trials. British Medical Journal, 313, 3 August 1996, 253-8 , 1997 .
[91] J. Gleitz,et al. Effects of Long-Term Administration of Hypericum Extracts on the Affinity and Density of the Central Serotonergic 5-HT1 A and 5-HT2 A Receptors , 1997, Pharmacopsychiatry.
[92] A. Nahrstedt,et al. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. , 1997, Pharmacopsychiatry.
[93] J. Brockmöller,et al. Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in Humans , 1997, Pharmacopsychiatry.
[94] V. Eu,et al. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. , 1997 .
[95] U. Hafner,et al. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. , 1997, Pharmacopsychiatry.
[96] S. Kasper,et al. Treatment of Seasonal Affective Disorder (SAD) with Hypericum Extract , 1997, Pharmacopsychiatry.
[97] J. Czekalla,et al. The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine. , 1997, Pharmacopsychiatry.
[98] J. Cott. In Vitro Receptor Binding and Enzyme Inhibition by Hypericum perforatum Extract , 1997, Pharmacopsychiatry.
[99] A. Nahrstedt,et al. Biologically Active and Other Chemical Constituents of the Herb of Hypericum perforatum L. , 1997, Pharmacopsychiatry.
[100] J. Ring,et al. Reversible Erhöhung der Photosensitivität im UV-B-Bereich durch Johanniskrautextrakt- Präparate , 1997, Der Hautarzt.
[101] J. Brockmöller,et al. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin , 1996, Antimicrobial agents and chemotherapy.
[102] C. Mulrow,et al. St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.
[103] J. Brockmöller,et al. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers. , 1994, Journal of geriatric psychiatry and neurology.
[104] H. Woelk,et al. Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients. , 1994, Journal of geriatric psychiatry and neurology.
[105] H M Thiede,et al. Inhibition of MAO and COMT by hypericum extracts and hypericin. , 1994, Journal of geriatric psychiatry and neurology.
[106] H. Wagner,et al. Inhibition of MAO by Fractions and Constituents of Hypericum Extract , 1994, Journal of geriatric psychiatry and neurology.
[107] M. Ploch,et al. Modulation of Cytokine Expression by Hypericum Extract , 1994, Journal of geriatric psychiatry and neurology.
[108] J. Mortimer,et al. Cognitive Performance Test: A New Approach to Functional Assessment in Alzheimer's Disease , 1994 .
[109] J. Hölzl,et al. Pharmacokinetic Test of [14 C]-Labelled Hypericin and Pseudohypericin from Hypericum perforatum and Serum Kinetics of Hypericin in Man , 1991 .
[110] S. Okpanyi,et al. [Genotoxicity of a standardized Hypericum extract]. , 1990, Arzneimittel-Forschung.
[111] O. Schimmer,et al. The mutagenic potencies of plant extracts containing quercetin in Salmonella typhimurium TA98 and TA100. , 1988, Mutation research.
[112] H. Wagner,et al. Inhibition of Monoamine Oxidase by Hypercin , 1984 .
[113] C. Klier,et al. St. John's wort (Hypericum perforatum)--is it safe during breastfeeding? , 2002, Pharmacopsychiatry.
[114] J. D. Stewart,et al. Effect of prenatally administered hypericum (St John's wort) on growth and physical maturation of mouse offspring. , 2001, American journal of obstetrics and gynecology.
[115] C. Mulrow,et al. St John's wort for depression. , 2000, The Cochrane database of systematic reviews.
[116] T. Breidenbach,et al. Drug interaction of St John's wort with cyclosporin. , 2000, Lancet.
[117] D. Wheatley,et al. Hypericum in seasonal affective disorder (SAD). , 1999, Current medical research and opinion.
[118] M. Groves. Hypericum perforatum L. , 1998 .
[119] J. Cott. NCDEU update. Natural product formulations available in europe for psychotropic indications. , 1995, Psychopharmacology bulletin.
[120] E. Ford,et al. An investigation of the type of photosensitization caused by the ingestion of St John's Wort (Hypericum perforatum) by calves. , 1981, Journal of comparative pathology.